InCROM CHINA's Clinical Network
Study Sites
| Study Focus | Nature of Facility |
|---|---|
| PI-IV | SFDA-approved hospitals including many 1st class hospitals recognised nationwide |
| Hypertension | Japan-China Clinical Trial Centre of Hypertension (JCCTCH) inside Ruijin Hospital in Shanghai |
| Province / Area | No. of Affiliates | Province / Area | No. of Affiliates |
|---|---|---|---|
| Shanghai | 20 | Beijing | 15 |
| Jiangsu | 15 | Guangdong | 11 |
| Zhejiang | 6 | Shandong | 8 |
| Sichuan | 5 | Chongqing | 5 |
| Tianjin | 6 | Anhui | 2 |
| Jilin | 4 | Shaanxi | 4 |
| Heilongjiang | 3 | Guangxi | 4 |
| Hebei | 3 | Liaoning | 2 |
| Yunnan | 3 | Hubei | 5 |
| Jiangxi | 2 | Henan | 2 |
| Gansu | 4 | Inner Mongolia | 1 |
| Hunan | 3 | Fujian | 3 |
| Shanxi | 1 | Hainan | 2 |
| TOTAL | 139 |
(May 31, 2010)
Geographical representation of our clinical network

* Numbers indicated are the numbers of study sites in the area
* Red font indicate our office locations




